👁️GURU.Markets👁️

🛒 tuku 1 000

🌙

☀️

BHVN Total Utang marang Modal Biohaven

Test results for anti-epileptic molecules determine the development vector of Biohaven Ltd. (BHVN), influencing the dynamics of asset leverage, which this chart on GURU.Markets reflects via the value of 24.82. Its status as a neuromedicine innovator ensures physician trust, while patent protection allows the company to maintain premium pricing for unique drugs, strengthening the business's financial stability.

BHVN: Total Utang marang Modal Biohaven 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan Biohaven Corp (BHVN)

- rega lan prakiraan konsensus rega:

Bagan rega Biohaven|BHVN - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Kapitalisasi pasar Biohaven|BHVN - Total Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham Biohaven|BHVN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku biohavenpharma.com|BHVN - Nilai Agregat Aset

- data utang lan likuiditas:

Utang marang Ekuitas Biohaven Ltd.|BHVN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Biohaven Ltd.|BHVN - Utang perusahaan|Utang-utang marang kapitalisasi buku Biohaven|BHVN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Biohaven

Analisis dhasar perusahaan:Biohaven - BHVN

Sampel barang Biohaven Corp

The total debt-to-equity ratio measures the proportion of borrowed funds relative to a company's own resources to assess financial stability. For Biohaven Ltd. (BHVN), this balance is critical when financing the commercialization of neurological drugs and the development of taladepant. By analyzing the proportion of total debt to equity, an investor determines the risk of default or the underutilization of financial leverage. A decrease in this metric confirms a strengthening balance sheet. An optimal value ensures growth rates without an excessive debt burden.

Pesaing wigati

Utang marang Ekuitas Biogen (BIIB)|Rasio Utang marang Ekuitas Neurocrine|Regencell - Total Utang marang Modal|Utang marang Modal Axsome Corp AXSM|Rasio Total Utang marang Ekuitas ACAD (ACADIA Pharmaceuticals)|xenon-pharma.com - Total Utang marang Modal|Utang marang Ekuitas Viking Therapeutics, Inc. (VKTX)|SUPN: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas CPRX|Denali Corp (DNLI) - Utang marang Modal|Total Utang marang Modal Harmony Biosciences|Utang marang Ekuitas amylyx.com|TRVI (Trevi Therapeutics, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal PRAX (Praxis Precision Medicines Inc)|AVXL: Utang marang Ekuitas|Utang marang Modal CeriBell EEG CBLL|Total Utang marang Modal Prothena Corporation plc (PRTA)|ALEC - Rasio Kabeh Utang marang Dana Pribadi|ANNX: Total Utang marang Modal|Total Utang marang Modal Omeros|Rasio Total Utang marang Ekuitas Neurogene Corp|Utang marang Ekuitas AC Immune Inc|Voyager Therapeutics - Total Utang marang Modal|Utang marang Modal NMRA (neumoratx.com)|SCLX - Utang marang Ekuitas|TVGN - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Alpha Cognition Corp (ACOG)|CGTX: Rasio Kabeh Utang marang Dana Pribadi|Inhibikase Therapeutics (IKT) - Utang marang Ekuitas|Utang marang Ekuitas cassavasciences.com|Assertio Holdings (ASRT) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Coya|Total Utang marang Modal Vistagen Therapeutics VTGN|Rasio Utang marang Ekuitas ovidrx.com OVID|Rasio Total Utang marang Ekuitas ABOS|Koefisien Total Utang marang Modal cervomed.com CRVO|ATHE - Total Utang marang Modal|CLNN - Utang marang Ekuitas|Total Utang marang Modal pepgen.com PEPG|Rasio Kabeh Utang marang Dana Pribadi Jupiter Neurosciences, Inc.|Rasio Total Utang marang Ekuitas Relmada Therapeutics|Utang marang Ekuitas ANVS|Utang marang Ekuitas Grace Therapeutics, Inc. GRCE|Rasio Utang marang Ekuitas AIFF (Firefly Neuroscience, Inc.)|KLTO - Utang marang Ekuitas|Rasio Utang marang Ekuitas NeuroSense Therapeutics Ltd NRSN|RVPH (Reviva Pharmaceuticals) - Total Utang marang Modal|MetaVia Inc (MTVA) - Utang marang Modal|NRXS: Rasio Total Utang marang Ekuitas|HSDT (Helius Medical Technologies) - Total Utang marang Modal|PASG - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi NEUP|Minerva Neurosciences - Utang marang Ekuitas|Utang marang Modal athira.com (ATHA)|Total Utang marang Modal Addex Therapeutics Ltd ADXN|Utang marang Ekuitas Alzamend Neuro Inc. ALZN|Total Utang marang Modal CYCN (Cyclerion)|PTIX: Koefisien Total Utang marang Modal|Utang marang Ekuitas KTTA|Cortigent (CRGT) - Utang marang Modal|ATXI - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Brainstorm Cell Therapeutics Inc.|Total Utang marang Modal CARA|Total Utang marang Modal Chromocell CHRO|Rasio Total Utang marang Ekuitas Eliem Therapeutics Inc. ELYM|Utang marang Ekuitas Intra-Cellular Therapies Inc. ITCI|LBPH (Longboard Pharmaceuticals, Inc.) - Total Utang marang Modal|MRNS: Utang marang Modal|Utang marang Ekuitas NKGen|Rasio Utang marang Ekuitas NeuroBo Pharma|SAGE - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SNPX|Utang marang Ekuitas Trevena (TRVN)|Utang marang Ekuitas vigilneuro.com VIGL|Rasio Total Utang marang Ekuitas Anew Medical (WENA)|Utang Agregat marang Modal Cerevel Corp CERE